Investor directoryVersant Ventures
Versant Ventures leverages scientific expertise and partnerships with academic institutions to create innovative biotech companies.
What they invest in
Sectors
Geographies
global
In numbers
In the last 24 months, Versant Ventures took part in 3 funding rounds on record at Oka. The most recent round on record is from October 2026.
As of October 2026. Source: Oka, counted from funding rounds reported in the press; rounds that were never reported are not included.
The facts
- Typical cheque
- €2M – €75M
- Headquarters
- Switzerland
- Founded
- 1999
Portfolio companies
More portfolio companies
Jade Biosciences (NAS: JBIO)CRISPR Therapeutics (NAS: CRSP)BlueRock TherapeuticsBorealis BiosciencesCapsida BiotherapeuticsChinook TherapeuticsAbdera TherapeuticsSixPeaks BioVectivBioBright Peak TherapeuticsCentury Therapeutics (NAS: IPSC)RayzeBioHalioLava TherapeuticsTurnstone BiologicsGraphite BioVividion TherapeuticsPassage Bio (NAS: PASG)Ventus TherapeuticsLight Horse TherapeuticsNexo TherapeuticsTentarix BiotherapeuticsLycia TherapeuticsBlack Diamond Therapeutics (NAS: BDTX)
and 26 more
Questions founders ask
- How much does Versant Ventures typically invest?
- Versant Ventures states a typical cheque of €2M – €75M.
- Which stages does Versant Ventures invest in?
- Versant Ventures invests at Series A, Series B, Pre-Seed and Seed.
- Where is Versant Ventures based?
- Versant Ventures is headquartered in Switzerland.
Does Versant Ventures fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you Versant Ventures? Tell us what to correct and we will update it — or ask us to remove the entry.